SLC16A1 and neoplasm: By virtue of this anti-VEGF/anti-MCT1 combinatorial strategy we anticipated to antagonize not only the oxygenated/aerobe compartment of the tumor mass via AVA but also to starve the hypoxic cells via CHC or AZD3965.